INBX(INBX)
INBX
Signal
Leaning Bullish1↑1!
PRICE
Prev Close
128.79
Open
127.99
Day Range127.99 – 134.40
127.99
134.40
52W Range10.84 – 155.29
10.84
155.29
84% of range
VOLUME & SIZE
Avg Volume
300.7K
FUNDAMENTALS
P/E Ratio
-14.5x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
2.18
High vol
Performance
1D↓
-0.33%5D
-0.15%1M
+102.12%3M
+56.00%6M
+57.08%YTD
+63.03%1Y↑
+944.53%Best: 1Y (+944.53%)Worst: 1D (-0.33%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev +550% · -91% gross marginValuation
FAIR
P/E not availableHealth
WEAK
CR 3.9 · FCF negativeLean Bearish
Key MetricsTTM
Market Cap$1.95B
Revenue TTM$1.30M
Net Income TTM-$140.06M
Free Cash Flow-$129.82M
Gross Margin-91.0%
Net Margin-10773.5%
Operating Margin-10386.5%
Return on Equity-269.6%
Return on Assets-95.6%
Debt / Equity13.39
Current Ratio3.93
EPS TTM$-9.04
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong4 concern
33/100Liquidity
3.93Strong
Leverage
13.39Concern
Coverage
-11.1xConcern
ROE
-269.6%Concern
ROIC
-117.4%Concern
Cash
$124MStrong
Analyst Coverage
No analyst coverage available for this stock.
Stock Health
Composite Score
2 of 4 signals bullish
7/10
Technicals
●
~RSI RangeRSI 79 — Overbought, caution
Volume
●
✓Volume FlowAccumulation — institutional buying
Fundamentals
●
✗Last EarningsMissed estimates
●
✓LiquidityCurrent Ratio 3.93 — healthy liquidity
1 signal unavailable — limited data for this stock
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▲ UptrendGolden Cross · 50D leads 200D by 44.4%
+75.5% vs SMA 50 · +153.5% vs SMA 200
Momentum
RSI79.1Overbought — pullback risk
MACD-3.55Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$155.3+18.1%
Current
$131.5
EMA 50
$72.82-44.6%
EMA 200
$51.06-61.2%
52W Low
$10.84-91.8%
52-Week RangeNear 52-week high
$10.8484th %ile$155.3
Squeeze SetupVolume-based
Elevated Squeeze SetupStrong accumulation on above-average volume. Buyers are absorbing supply aggressively — any positive catalyst could trigger a rapid covering move.
20-Day Money Flow
Acc days:7
Dist days:2
Edge:+5 acc
Volume Context
Avg Vol (50D)107K
Recent Vol (5D)
130K+22%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
Earnings HistoryINBX
Last 8Q
+445.3%avg beat
Beat 3 of 8 quartersMissed 5↑ Estimates rising-38%
Q2'24
+3586%
Q3'24
+7%
Q4'24
-7%
Q1'25
-10%
Q2'25
+37%
Q3'25
-10%
Q4'25
-1%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightFinancials
INSTITUTIONAL OWNERSHIP
1
Nuveen, LLC
17K▲2
Ethic Inc.
9K▼3
PROFUND ADVISORS LLC
7K▲4
Janney Montgomery Scott LLC
6K▲5
NBC SECURITIES, INC.
4K▲6
Presidio Capital Management, LLC
3K—7
Moran Wealth Management, LLC
3K▲8
Police & Firemen's Retirement System of New Jersey
3K—News & Activity
INBX News
Unable to load news
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Mark Paul Lappe
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
INBX◀ | $131.48 | -0.33% | $1.9B | — | +55000.0% | -1077346.2% | 1500 |
| $68.91 | -3.59% | $13.3B | — | +12626.1% | -14525.8% | 1500 | |
| $520.84 | -0.71% | $11.8B | — | +43205.3% | -3008.0% | 1500 | |
| $88.52 | +0.60% | $11.5B | — | +3288.2% | -4239.0% | 1500 | |
| $181.75 | -1.59% | $10.7B | 29.2 | +1871.5% | 680.1% | 1500 | |
| $228.45 | -0.59% | $10.6B | — | +6554.5% | -2868.8% | 1500 | |
| $75.32 | +1.81% | $10.5B | 51.8 | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -0.63% | — | 40.5 | +349765.8% | -157332.5% | 1500 |